Hospital
Memorial Health Care System INC.
Memorial Health Care System INC. was paid $2.38M by Medicaid between Jan 2018 and Nov 2024, across 49 billing codes. Its largest line is 99284, emergency room visit (serious) — 48% of everything it billed.
33Billing provider infoMEMORIAL HEALTH CARE SYSTEM INC.
HIXSON, TN 37343
HIXSON, TN 37343
33aNPI1083778633assigned 12/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.38M
24GClaims69,172
24DCodes billed49
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#57 of 71
Median peer was paid$6.96M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,105 | $575K | |
| 2019 | 16,441 | $556K | |
| 2020 | 12,329 | $377K | |
| 2021 | 10,808 | $391K | |
| 2022 | 8,224 | $268K | |
| 2023 | 5,266 | $198K | |
| 2024incomplete | 999 | $18K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 48% | 9,208 | 7,648 | $1.14M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 9,397 | 8,355 | $746K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.5% | 960 | 801 | $178K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.6% | 2,429 | 1,961 | $61K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 10,868 | 8,985 | $58K |
| 84484 | 1.0% | 2,005 | 1,515 | $25K | |
| 80053 | Comprehensive metabolic panel | <1% | 4,375 | 3,650 | $19K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,774 | 2,972 | $17K |
| 87631 | <1% | 247 | 210 | $17K | |
| 84703 | <1% | 1,897 | 1,650 | $14K | |
| 83690 | <1% | 2,530 | 2,156 | $14K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 286 | 260 | $13K |
37 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,915 | $13K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 166 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,508 | $8K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,342 | $6K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 193 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 587 | $5K |
| 85730 | <1% | 1,247 | $4K | |
| 83735 | <1% | 1,048 | $4K | |
| 81001 | <1% | 4,292 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 750 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 275 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,304 | $3K |
| 85610 | <1% | 1,263 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 550 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 46 | $1K |
| 71250 | <1% | 24 | $857.04 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 20 | $621.96 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 123 | $576.53 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 74 | $548.43 |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 18 | $527.54 |
| 87070 | <1% | 116 | $487.12 | |
| 80076 | <1% | 120 | $309.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 84 | $273.94 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 62 | $242.45 |
| 87088 | <1% | 52 | $238.21 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 38 | $229.90 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 22 | $133.47 |
| 80305 | <1% | 17 | $90.40 | |
| 87077 | <1% | 19 | $89.35 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 36 | $25.52 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 996 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 43 | $0.00 |
| A9270 | Non-covered item or service | 0% | 21 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 18 | $0.00 |
| 82962 | 0% | 20 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 744 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSUTTON, MICHAEL (VICE PRESIDENT, FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Memorial Health Care System INC. | Chattanooga, TN | $4.08M |
| Philip R. Mill, Od and Michael D. Sutton, Od INC. | Pittsburg, CA | $420K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.